Skip to main content
. 2017 Aug 17;14(4):3602–3608. doi: 10.3892/etm.2017.4954

Figure 3.

Figure 3.

Viability of (A) splenocytes and (B) lymphocytes in rats undergoing different treatments. The rats were treated with Dex 10, LPS, Dex + LPS, YOH + Dex10 + LPS or YOH + LPS. There were no differences in the viability of splenocytes and lymphocytes in rats that had received different treatments. CTRL, control; LPS, lipopolysaccharide; Dex, dexmedetomidine; YOH, yohimbine; Dex 10, 10 µg/kg Dex.